Squamous Cell Carcinoma of the Head and Neck

3 competing products in clinical development for Squamous Cell Carcinoma of the Head and Neck.

Pipeline by Phase

Phase 11
Phase 32

All Products (3)

ProductCompanyStageStatusHype
Nivolumab + Cetuximab + Methotrexate + DocetaxelOno PharmaceuticalPhase 3Completed
40
Nivolumab + Cetuximab + CisplatinOno PharmaceuticalPhase 3Completed
40
Patritumab + Cetuximab + Cisplatin + CarboplatinDaiichi SankyoPhase 1Completed
29